One Firm's Focus Permits Another's Expansion
Executive Summary
SangStat Medical, a Menlo Park CA-based firm applying a disease-management approach to organ transplantation, announced in mid-April that it would acquire Imtix, the transplant-focused business unit of Pasteur Merieux Connaught. If the deal goes through, SangStat will have itself a turn-key European marketing operation, ready and able to sell Sang-35, its own formulation of anti-organ rejection drug cyclosporine.